The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ADVERUM BIOTECHNOLOGIES INC | COM NEW | 00773U207 | 21,209,986 | 1,499,999 | SH | SOLE | 1,499,999 | 0 | 0 | ||
AKERO THERAPEUTICS INC | COM | 00973Y108 | 20,208,000 | 800,000 | SH | SOLE | 800,000 | 0 | 0 | ||
ALLAKOS INC | COM | 01671P100 | 3,654,000 | 2,900,000 | SH | SOLE | 2,900,000 | 0 | 0 | ||
ALNYLAM PHARMACEUTICALS INC | COM | 02043Q107 | 74,725,000 | 500,000 | SH | Call | SOLE | 500,000 | 0 | 0 | |
ANNEXON INC | COM | 03589W102 | 21,868,500 | 3,050,000 | SH | SOLE | 3,050,000 | 0 | 0 | ||
ANNEXON INC | COM | 03589W102 | 7,170,000 | 1,000,000 | SH | Call | SOLE | 1,000,000 | 0 | 0 | |
APELLIS PHARMACEUTICALS INC | COM | 03753U106 | 47,024,000 | 800,000 | SH | SOLE | 800,000 | 0 | 0 | ||
APPLIED THERAPEUTICS INC | COM | 03828A101 | 8,976,000 | 1,350,000 | SH | SOLE | 1,350,000 | 0 | 0 | ||
ASTRIA THERAPEUTICS INC | COM | 04635X102 | 14,075,000 | 1,000,000 | SH | Call | SOLE | 1,000,000 | 0 | 0 | |
ASTRIA THERAPEUTICS INC | COM | 04635X102 | 17,522,812 | 1,244,960 | SH | SOLE | 1,244,960 | 0 | 0 | ||
ATYR PHARMA INC | COM NEW | 002120202 | 6,045,000 | 3,100,000 | SH | SOLE | 3,100,000 | 0 | 0 | ||
BOUNDLESS BIO INC | COM | 10170A100 | 2,850,000 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
CELLDEX THERAPEUTICS INC NEW | COM NEW | 15117B202 | 27,280,500 | 650,000 | SH | SOLE | 650,000 | 0 | 0 | ||
CG ONCOLOGY INC | COM | 156944100 | 13,170,000 | 300,000 | SH | SOLE | 300,000 | 0 | 0 | ||
COMPASS PATHWAYS PLC | SPONSORED ADS | 20451W101 | 1,813,599 | 257,980 | SH | SOLE | 257,980 | 0 | 0 | ||
CULLINAN ONCOLOGY INC | COM | 230031106 | 11,928,000 | 700,000 | SH | SOLE | 700,000 | 0 | 0 | ||
CYBIN INC | COM | 23256X100 | 16,540,000 | 40,000,000 | SH | SOLE | 40,000,000 | 0 | 0 | ||
CYTOKINETICS INC | COM NEW | 23282W605 | 7,011,000 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
DESIGN THERAPEUTICS INC | COM | 25056L103 | 20,280,979 | 5,032,501 | SH | SOLE | 5,032,501 | 0 | 0 | ||
DYNE THERAPEUTICS INC | COM | 26818M108 | 49,114,700 | 1,730,000 | SH | SOLE | 1,730,000 | 0 | 0 | ||
ELEVATION ONCOLOGY INC | COM | 28623U101 | 5,130,000 | 1,000,000 | SH | SOLE | 1,000,000 | 0 | 0 | ||
ENGENE HOLDINGS INC | COM | 29286M105 | 12,882,000 | 800,000 | SH | SOLE | 800,000 | 0 | 0 | ||
ENLIVEN THERAPEUTICS INC | COM | 29337E102 | 26,408,383 | 1,574,220 | SH | SOLE | 1,574,220 | 0 | 0 | ||
FULCRUM THERAPEUTICS INC | COM | 359616109 | 9,440,000 | 1,000,000 | SH | Call | SOLE | 1,000,000 | 0 | 0 | |
GERON CORP | COM | 374163103 | 29,700,000 | 9,000,000 | SH | SOLE | 9,000,000 | 0 | 0 | ||
IDEAYA BIOSCIENCES INC | COM | 45166A102 | 65,820,000 | 1,500,000 | SH | SOLE | 1,500,000 | 0 | 0 | ||
IMMATICS N.V | SHS | N44445109 | 10,510,000 | 1,000,000 | SH | SOLE | 1,000,000 | 0 | 0 | ||
IMMUNIC INC | COM | 4525EP101 | 555,963 | 421,184 | SH | SOLE | 421,184 | 0 | 0 | ||
IMMUNOCORE HLDGS PLC | ADS | 45258D105 | 58,500,000 | 900,000 | SH | SOLE | 900,000 | 0 | 0 | ||
IMMUNOVANT INC | COM | 45258J102 | 57,350,250 | 1,775,000 | SH | SOLE | 1,775,000 | 0 | 0 | ||
IO BIOTECH INC | COM | 449778109 | 854,321 | 493,827 | SH | SOLE | 493,827 | 0 | 0 | ||
JANUX THERAPEUTICS INC | COM | 47103J105 | 5,647,500 | 150,000 | SH | SOLE | 150,000 | 0 | 0 | ||
KURA ONCOLOGY INC | COM | 50127T109 | 6,399,000 | 300,000 | SH | SOLE | 300,000 | 0 | 0 | ||
KYVERNA THERAPEUTICS INC | COM | 501976104 | 12,420,000 | 500,000 | SH | SOLE | 500,000 | 0 | 0 | ||
LARIMAR THERAPEUTICS INC | COM | 517125100 | 5,313,000 | 700,000 | SH | Call | SOLE | 700,000 | 0 | 0 | |
LEAP THERAPEUTICS INC | COM NEW | 52187K200 | 105,070 | 39,500 | SH | SOLE | 39,500 | 0 | 0 | ||
LINEAGE CELL THERAPEUTICS IN | COM | 53566P109 | 9,250,000 | 6,250,000 | SH | SOLE | 6,250,000 | 0 | 0 | ||
NEUMORA THERAPEUTICS INC. | COM | 640979100 | 6,193,033 | 382,345 | SH | SOLE | 382,345 | 0 | 0 | ||
NEXTCURE INC | COM | 65343E108 | 4,292,750 | 1,925,000 | SH | SOLE | 1,925,000 | 0 | 0 | ||
NUVATION BIO INC | *W EXP 07/07/202 | 67080N119 | 22,743 | 66,666 | SH | SOLE | 66,666 | 0 | 0 | ||
OCULAR THERAPEUTIX INC | COM | 67576A100 | 51,991,614 | 5,811,436 | SH | SOLE | 5,811,436 | 0 | 0 | ||
OLEMA PHARMACEUTICALS INC | COM | 68062P106 | 49,625,465 | 4,383,875 | SH | SOLE | 4,383,875 | 0 | 0 | ||
PRAXIS PRECISION MEDICINES I | COM NEW | 74006W207 | 9,153,000 | 150,000 | SH | SOLE | 150,000 | 0 | 0 | ||
ROCKET PHARMACEUTICALS INC | COM | 77313F106 | 35,022,000 | 1,300,000 | SH | SOLE | 1,300,000 | 0 | 0 | ||
SAREPTA THERAPEUTICS INC | COM | 803607100 | 51,784,000 | 400,000 | SH | SOLE | 400,000 | 0 | 0 | ||
SAREPTA THERAPEUTICS INC | COM | 803607100 | 155,352,000 | 1,200,000 | SH | Call | SOLE | 1,200,000 | 0 | 0 | |
SILENCE THERAPEUTICS PLC | ADS | 82686Q101 | 31,085,914 | 1,476,061 | SH | SOLE | 1,476,061 | 0 | 0 | ||
SPYRE THERAPEUTICS INC | COM NEW | 00773J202 | 9,482,500 | 250,000 | SH | SOLE | 250,000 | 0 | 0 | ||
STRUCTURE THERAPEUTICS INC | SPONSORED ADS | 86366E106 | 30,861,686 | 720,058 | SH | SOLE | 720,058 | 0 | 0 | ||
STRUCTURE THERAPEUTICS INC | SPONSORED ADS | 86366E106 | 19,287,000 | 450,000 | SH | Call | SOLE | 450,000 | 0 | 0 | |
SYNDAX PHARMACEUTICALS INC | COM | 87164F105 | 8,330,000 | 350,000 | SH | SOLE | 350,000 | 0 | 0 | ||
TOURMALINE BIO INC | COM | 89157D105 | 2,271,863 | 99,208 | SH | SOLE | 99,208 | 0 | 0 | ||
TREVI THERAPEUTICS INC | COM | 89532M101 | 7,590,000 | 2,200,000 | SH | SOLE | 2,200,000 | 0 | 0 | ||
UNICYCIVE THERAPEUTICS INC | COM | 90466Y103 | 3,010,856 | 3,469,927 | SH | SOLE | 3,469,927 | 0 | 0 | ||
VERA THERAPEUTICS INC | CL A | 92337R101 | 24,794,000 | 575,000 | SH | SOLE | 575,000 | 0 | 0 | ||
VIRIDIAN THERAPEUTICS INC | COM | 92790C104 | 12,257,000 | 700,000 | SH | SOLE | 700,000 | 0 | 0 | ||
XENCOR INC | COM | 98401F105 | 14,384,500 | 650,000 | SH | SOLE | 650,000 | 0 | 0 |